# A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS

> **NCT00349531** · PHASE4 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 369 (actual)

## Conditions studied

- Restless Legs Syndrome

## Interventions

- **DRUG:** Pramipexole

## Key facts

- **NCT ID:** NCT00349531
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2007-05
- **Final completion:** —
- **Target enrollment:** 369 (ACTUAL)
- **Last updated:** 2012-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00349531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00349531, "A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00349531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*